| Ticker | Status | Jurisdiction | Filing Date | CP Start | CP End | CP Loss | Deadline |
|---|
| Ticker | Case Name | Status | CP Start | CP End | Deadline | Settlement Amt |
|---|
| Ticker | Name | Date | Analyst Firm | Up/Down | Target ($) | Rating Change | Rating Current |
|---|
Corcept Therapeutics (NASDAQ:CORT) reported its Q4 earnings results on Thursday, February 15, 2024 at 04:05 PM.
Here's what investors need to know about the announcement.
Corcept Therapeutics beat estimated earnings by 7.69%, reporting an EPS of $0.28 versus an estimate of $0.26.
Revenue was up $32.35 million from the same period last year.
Last quarter the company beat on EPS by $0.07 which was followed by a 9.97% drop in the share price the next day.
Here's a look at Corcept Therapeutics's past performance:
| Quarter | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 |
|---|---|---|---|---|
| EPS Estimate | 0.21 | 0.15 | 0.19 | 0.22 |
| EPS Actual | 0.28 | 0.25 | 0.14 | 0.14 |
| Revenue Estimate | 119.34M | 109.71M | 104.87M | 105.08M |
| Revenue Actual | 123.60M | 117.72M | 105.65M | 103.06M |
To track all earnings releases for Corcept Therapeutics visit their earnings calendar here.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
Posted In: CORT
